GROSSMAN D KEITH Acquires Nevro Corp. (NVRO) Shares

Nevro Corp. (NYSE:NVRO) finished Friday with an addition of $1.02 to close at $121.29, an upside of 0.85 percent. An average of 283,640 shares of common stock have been traded in the last five days. There was a gain of $4.62 in the past week, and it reached a new high 6 times over the past 12 months. The last 20 days have seen an average of 290,635 shares traded, while the 50-day average volume stands at 417,016.

NVRO stock has decreased by -0.55% in the last month. The company shares reached their 1-month lowest point of $110.78 on 10/18/21. With the stock rallying to its 52-week high on 01/21/21, shares of the company touched a low of $99.54 and a high of $188.14 in 52 weeks. It has reached a new high 5 times so far this year and lost -29.93% or -$51.81 in price. In spite of this, the price is down -35.53% from the 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Insider Transactions

123 days have passed since Nevro Corp. (NVRO) last reported insider trading activity. DEMANE MICHAEL F, who is Director, most recently acquired $6,445 shares at $179.03 per share on Jun 22. In this transaction, the insider spent $1,153,837. Director, McCormick Shawn, disposed of 482 shares at a price of $149.65 on May 24. The insider now owns more than $72,131 worth of shares. Prior to that, Chief Commercial Officer Pellegrini Niamh Louise went on to Sale 750 shares at $148.08 each on Mar 10. An amount of $111,060 was transacted.

Valuation Metrics

Nevro Corp. (NVRO) has a trailing price-to-earnings (P/E) ratio of 26.30 for the broader industry and 33.43 for the sector. The stock’s beta is 1.02. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 10.33, the price-to-book (PB) ratio at 11.78, and the price-to-cash flow ratio at 5283.70.

The quick ratio of Nevro Corp. for the three months ended June 29 was 6.40, and the current ratio was 7.50, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.41 and a total debt to equity ratio of 0.41 for the quarter ending June 29. Nevro Corp.’s EBITDA margin for the year ending June 29 is -15.10%, while its operating margin for the same period stands at -10.40%. Its gross profit as reported stood at $249.9 million compared to revenue of $362.05 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Nevro Corp.’s return on assets was -9.30%. For the broader industry, ROE averaged 3.96 over the past year.

Earnings Surprise

For the three-month period that ended June 29, Nevro Corp. had $251.49 million in cash and short-term investments compared to $146.42 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$21.59 million in the quarter, while revenues of -$29.56 million were shrunk -90.18%. The analyst consensus anticipated Nevro Corp.’s latest quarter earnings to come in at -$0.73 per share, but it turned out to be -$0.62, a 15.10% surprise. For the quarter, EBITDA amounted to -$5.02 million. Shareholders own equity worth $34.87 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Nevro Corp. (NVRO) price momentum. RSI 9-day as of the close on 22 October was 62.61%, suggesting the stock is Neutral, with historical volatility in this time frame at 27.10%.

As of today, NVRO’s price is $118.51 +3.96% or $4.62 from its 5-day moving average. NVRO is currently trading +0.91% higher than its 20-day SMA and -17.57% lower than its 100-day SMA. However, the stock’s current price level is +15.76% above the SMA50 and -25.83% below the SMA200.

The stochastic %K and %D were 86.91% and 73.57%, respectively, and the average true range (ATR) was 3.73. With the 14-day stochastic at 95.85% and the average true range at 3.86, the RSI (14) stands at 55.66%. The stock has reached 2.86 on the 9-day MACD Oscillator while the 14-day reading was at 3.15.

Analyst Ratings

William Blair downgraded Nevro Corp. (NYSE: NVRO) to a a Mkt perform rating in its most recent analyst report. Previously, the stock was rated as an Outperform. The consensus rating for Nevro Corp. (NVRO) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell NVRO, while 10 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 6 others rate it as a “buy”.

What is NVRO’s price target for the next 12 months?

Analysts predict a range of price targets between $120.00 and $165.00, with a median target of $131.00. Taking a look at these predictions, the average price target given by analysts for Nevro Corp. (NVRO) stock is $139.62.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam